Wells Pharmacy Network
Multi-site network running a 503A pharmacy in Florida and a 503B outsourcing facility in Tennessee. Named publicly by . What is checkable, and how to check it.
Updated 2026-09-18 · every price checked by hand
How we make money: one company on this page — Coreage Rx — pays us a commission when a reader signs up through our link. It buys them nothing else: not a better score, not a higher place in the table, not the removal of a single criticism. Our scoring method and full disclosure are both public.
Wells Pharmacy Network is multi-site network running a 503A pharmacy in Florida and a 503B outsourcing facility in Tennessee.
No provider we review names this pharmacy publicly. It appears here because it is widely reported as supplying compounded GLP-1s and because it has a published FDA record worth being able to look up — you may well be dispensed from it without ever being told.
What we can verify about Wells Pharmacy Network
| Wells Pharmacy Network | |
|---|---|
| Facility type | 503A pharmacy (Ocala, FL) and 503B outsourcing facility (Dyersburg, TN) |
| Location | Ocala, Florida and Dyersburg, Tennessee |
| Accreditation | None published |
| Named publicly by | No provider we review names it |
| FDA actions published | Yes — 8 entries |
- FDA lists two separate facilities: Wells Pharmacy Network, LLC in Ocala, Florida as a 503A, and Wells Pharmacy Network LLC in Dyersburg, Tennessee as a 503B outsourcing facility.
- Described in industry roundups as serving a prescriber network across all 50 states with hormone and weight-loss compounding as core categories.
- Reported as offering semaglutide, tirzepatide and liraglutide formulations.
That is the complete list of what we could confirm from published sources as of 2026-09-18. We have not filled the gaps with inference — if something is not above, we could not verify it.
Our read
The two-facility structure is the thing to understand. A 503A and a 503B under one brand means your prescription could be filled under either regime — state-board oversight or direct FDA inspection — and they have markedly different published records. The Tennessee 503B carries entries running into 2026; the Florida 503A has a single 2020 letter. If a provider tells you your medication comes from Wells, the useful follow-up is which site.
Who dispenses from it
No provider in our roster names this pharmacy publicly, so we cannot tell you who uses it. That is the normal situation in this market and it is the reason these pages exist — ask your provider directly which pharmacy fills your prescription, and check the answer against the FDA list below.
Being named by a provider does not mean that provider uses it exclusively, or that it will fill your particular prescription. Multi-pharmacy networks route by state and by product, so confirm which pharmacy serves you specifically.
FDA enforcement record
FDA publishes inspections, recalls and other actions for compounders. The entry below is quoted from that list as FDA states it. Read the glossary before drawing conclusions — most of these documents are not what people assume.
Listed as: Two entries: Wells Pharmacy Network, LLC, Ocala, FL — 503A Facility, and Wells Pharmacy Network LLC, Dyersburg, TN — 503B Facility
- 503A (Ocala, FL): FMD-145 Letter Issued 06/8/2020
- 503B (Dyersburg, TN): 483 issued 4/09/2026
- 503B (Dyersburg, TN): FMD-145 Letter Issued 03/26/2026
- 503B (Dyersburg, TN): Untitled Letter Issued 10/14/2025
- 503B (Dyersburg, TN): 483 Issued 04/25/2025
- 503B (Dyersburg, TN): Untitled Letter Issued 05/19/2022
- 503B (Dyersburg, TN): 483 Issued 01/28/2021
- 503B (Dyersburg, TN): FMD-145 Letter Issued 08/06/2020
Our note. No warning letter appears against either facility. The two sites are listed separately by FDA and their records should not be read as one.
How to read this fairly. A Form 483 records inspection observations, not proven violations, and a busy facility that FDA visits often will collect more of them than one nobody inspects. Absence from the list is not a clean bill of health — it can simply mean no inspection or no published action. And the legal entity matters: similarly-named companies are frequently different facilities with different records.
- Form 483 — a list of observations an investigator made during an inspection. It is not a finding of violation and not a penalty. Large, frequently-inspected facilities accumulate them.
- Warning Letter — more serious. FDA alleging significant violations and requiring a response.
- Warning Letter Close Out — FDA confirming the issues in a warning letter were resolved. When you see one, read it alongside the letter it closes.
- Untitled Letter — below the threshold of a warning letter; concerns raised without the same formal weight.
- FMD-145 Letter — correspondence about a facility’s registration or compounding status.
- State Referral Letter — FDA passing a matter to the state board of pharmacy.
Source: FDA, Compounding: Inspections, Recalls, and other Actions. Checked 2026-09-18. FDA updates this list, so confirm the current position before relying on it.
How to verify Wells Pharmacy Network yourself
- Ask your provider, in writing, to confirm this is the pharmacy filling your prescription and whether it is a 503A pharmacy or a registered 503B outsourcing facility.
- Look the pharmacy up on the state board of pharmacy website for the state it operates from. Boards publish public licence lookup tools, and licences are public records.
- Check whether it holds voluntary accreditation. PCAB accreditation is administered through ACHC, which publishes an accredited-organisation search; NABP runs its own three-year Compounding Pharmacy Accreditation and provides a form for checking status.
- Ask for a certificate of analysis for your batch. Most will not offer one unprompted; the response you get is informative either way.
- If your provider will not name the pharmacy at all, that is the answer to your question — see how to spot a bad seller.
Accreditation is voluntary and its absence is not proof of a problem — plenty of properly licensed pharmacies do not carry it. Both NABP and PCAB evaluate compliance with USP standards through on-site inspection and documentation review, which is why it is a meaningful signal when present.
Where to get a GLP-1 prescription
A compounding pharmacy cannot sell you a GLP-1 directly — it fills a prescription written by a licensed clinician. So the practical route is a telehealth provider who prescribes and arranges dispensing.
Our featured provider is [Coreage Rx](/reviews/coreage-rx-tirzepatide-reviews), which prices compounded tirzepatide from $149 a month and semaglutide from $99 on the annual plan, flat at every dose and with no membership fee. That is a paid placement and we say so on every page it appears — see our disclosure. Check current pricing.
An honest caveat about our own recommendation. Coreage Rx does not publish which compounding pharmacy fills its prescriptions, so we cannot tell you it uses this one or any other — and we are not going to imply it. If pharmacy provenance is your priority, the providers that do name their pharmacies are listed on how to spot a bad seller. Ask any provider the question directly and get the answer in writing.
Common questions
Can I buy from Wells Pharmacy Network directly?
No. A compounding pharmacy dispenses against a prescription from a licensed clinician — it is not a shop. Anyone offering to sell you a compounded GLP-1 without a prescription is not operating legally, whatever pharmacy name is attached.
Does a named pharmacy mean the medication is FDA-approved?
No, and this is the distinction that matters most. A compounded preparation is not FDA-approved regardless of how well-regarded the pharmacy is. The pharmacy is licensed and may be accredited; the preparation itself has not been reviewed by the FDA for safety, effectiveness or manufacturing quality.
What is 503A, briefly?
A 503A pharmacy compounds for an individual patient against a specific prescription and is regulated primarily by state boards of pharmacy. A 503B outsourcing facility can produce larger batches, registers with the FDA and is subject to FDA inspection. Full explanation in is compounded GLP-1 still legal.
Verified 2026-09-18 from published sources. We are not affiliated with Wells Pharmacy Network and this is not an endorsement of any particular pharmacy — it is a record of what is publicly checkable.